secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2024-08-15T23:59:59+00:00
Accession:  0001654954-24-010758
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Catheter Precision Q2 revenue $93K, net loss $4.2M; cash only $16K at June 30
-----------------------------------------------------------------------------

- Q2 revenue $93K, H1 $175K; net loss Q2 $4.2M, H1 $6.9M.
- Cash at June 30 just $16K; rose to $330K by Aug 12 but remains extremely low.
- First commercial LockeT sales in US: $38K in both Q2 and H1; 23 hospitals scheduling evaluations.
- Total assets $26M, shareholders' equity $14.3M as of June 30.
- 14 new sales/clinical hires; VIVO evaluation started in Italy; VIVO EU Registry completed in June.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424010758/0001654954-24-010758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000165495424010758/vtak_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-010758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer